U.S. Markets open in 6 hrs 5 mins
  • S&P Futures

    3,820.25
    -7.75 (-0.20%)
     
  • Dow Futures

    31,255.00
    -116.00 (-0.37%)
     
  • Nasdaq Futures

    12,800.00
    -31.75 (-0.25%)
     
  • Russell 2000 Futures

    2,179.80
    -20.20 (-0.92%)
     
  • Crude Oil

    62.76
    -0.77 (-1.21%)
     
  • Gold

    1,758.80
    -16.60 (-0.93%)
     
  • Silver

    26.94
    -0.74 (-2.69%)
     
  • EUR/USD

    1.2155
    -0.0031 (-0.2553%)
     
  • 10-Yr Bond

    1.5180
    0.0000 (0.00%)
     
  • Vix

    28.89
    +7.55 (+35.38%)
     
  • GBP/USD

    1.3930
    -0.0082 (-0.5879%)
     
  • USD/JPY

    106.0610
    -0.1690 (-0.1591%)
     
  • BTC-USD

    45,222.62
    -5,318.56 (-10.52%)
     
  • CMC Crypto 200

    902.43
    -30.70 (-3.29%)
     
  • FTSE 100

    6,595.15
    -56.81 (-0.85%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

D.A. Davidson Sees Nautilus As Well-Equipped For Long-Term Success

Dwight Einhorn

In a report published Monday, D.A. Davidson analyst Andrew Burns reiterated a Buy rating and $18.00 price target on Nautilus, Inc. (NYSE: NLS).

In the report, D.A. Davidson noted, “We expect a positive 4Q with continued momentum into 2015. In recent weeks we hosted investor meetings with NLS management and studied the exercise equipment retail landscape to gauge the traction of NLS' new and existing product lines. We are encouraged by management's strong execution and long-term growth vision. On the retail front, our checks show continued strength of the Schwinn cardio line and broad availability of the new Nautilus line across most key retailer ecommerce platforms. We believe both the direct and retail segments will perform during the important 4Q-1Q sales period. Similar to the last two years, Nautilus should provide a favorable business update on 4Q trends at the upcoming ICR XChange conference (Jan. 12th-14th).”

Nautilus closed on Friday at $14.74.

Latest Ratings for NLS

Nov 2014

CRT Capital

Maintains

Buy

Nov 2014

Wunderlich

Maintains

Buy

Oct 2014

Wunderlich

Initiates Coverage on

Buy

View More Analyst Ratings for NLS
View the Latest Analyst Ratings

See more from Benzinga

© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.